Ovarian Cancer | Tumor

CURE’s ovarian cancer page is a go-to resource for oncology news and updates in the world of ovarian cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in ovarian cancer.

Proper Staging of Early-Stage Ovarian Cancer Before Treatment Provides Critical Information for Potentially Improved Outcomes

January 5th 2021, 7:00pm

Article

A gynecologic oncology expert from the University of California, Davis reviewed early-stage ovarian cancer and the importance of knowing what options are available before, during and after treatment.

7 Ovarian Cancer News and Updates That Patients May Have Missed in 2020

January 4th 2021, 10:00pm

Article

A roundup of some ovarian cancer news and updates that occurred in 2020 that patients may have missed.

Combination Treatment Increases Quality of Life for Patients With Ovarian Cancer

December 28th 2020, 10:00pm

Article

Women with ovarian cancer report a better quality of life when treated with a combination of Keytruda, Avastin and oral metronomic cyclophosphamide.

Keytruda Combo Therapy Demonstrates Clinical Benefit and Durable Treatment Response in Recurrent Ovarian Cancer

December 22nd 2020, 10:00pm

Article

Keytruda (pembrolizumab), Avastin (bevacizumab) and cyclophosphamide contributed to a clinical benefit in 95% of women in the trial and a durable treatment response of 12 months or longer in 25% of women.

Ovarian Cancer Heroes 2020

October 17th 2020, 10:00pm

Video

Watch the entire Ovarian Cancer Heroes program right here!

CURE®’s Annual Ovarian Cancer Heroes Program Goes Virtual Amid COVID-19 to Honor Three Women Who Have Dedicated Their Lives to Patients with Gynecologic Cancer

October 17th 2020, 1:00pm

Article

An oncology nurse, patient turned advocate and cancer biologist were honored during CURE®’s third annual Ovarian Cancer Heroes program where they got to share messages of resiliency with a virtual audience.

How COVID-19 Robs Patients with Cancer of Their Precious Time

October 6th 2020, 4:00pm

Article

Time is a valuable commodity, especially for patients with cancer who may find themselves with limited time or limited free time to enjoy the things they loved prior to their cancer. But the COVID-19 pandemic is robbing patients of that precious time.

Long-Term Evidence Confirms Benefit of Approved Lynparza Maintenance Strategy in Advanced Ovarian Cancer

September 29th 2020, 7:00pm

Article

Five-year follow-up data from the phase 3 SOLO-1 trial demonstrates a nearly five-year delay in disease progression with Lynparza compared with a delay of just over a year with placebo in women with newly diagnosed, advanced ovarian cancer harboring a BRCA gene mutation.

Dose-Dense Chemo Regimen No Better Than Standard of Care for Epithelial Ovarian Cancer

September 28th 2020, 6:00pm

Article

A weekly high dose of chemotherapy did not improve survival for patients with epithelial ovarian cancer, though the treatment regimen was effective and well-tolerated.

Study Finds Premenopausal Women Facing Increased Ovarian Cancer Risk Favor Removing Fallopian Tubes But Save Ovaries

September 11th 2020, 9:00pm

Article

A proposed preventive surgery that would take out fallopian tubes before menopause but save ovary removal until afterwards was favored by most premenopausal previvors of ovarian cancer in a study.